Advertisement
News
Advertisement

Allergan Lands a Date with the FDA

Tue, 03/19/2013 - 7:29am
Mass Device

Aesthetics giant Allergan wins a panel date with the FDA for review of its Juvéderm Voluma XC dermal filler.

MassDevice On Call

Aesthetic medical device maker Allergan (NYSE:AGN) will get a date with the FDA to review clinical data for the company's Juvéderm Voluma XC dermal filler.

Allergan hopes to win indication for deep implantation for aesthetic restoration in the face, according to the FDA notice.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading